The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Interplay between coagulation and vascular inflammation in sickle cell disease
Open accessAbstract
Summary: Sickle cell disease is the most common inherited haematological disorder that leads to the irreversible damage of multiple organs. Although sickling of red blood cells and vaso‐occlusion are central to the pathophysiology of sickle cell disease, the importance of haemolytic anaemia and vasculopathy has been recently recognized. A hypercoagulable state is another prominent feature of sickle cell disease and is mediated by activation of both intrinsic and extrinsic coagulation pathways. Growing evidence demonstrates that coagulation may not only contribute to the thrombotic complications, but also to vascular inflammation associated with this disease. This article summarizes the role of vascular inflammation and coagulation activation, discusses potential mechanisms responsible for activation of coagulation and reviews recent data demonstrating the crosstalk between coagulation and vascular inflammation in sickle cell disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
Charache, S., Terrin, M. L., Moore, R. D., Dover, G. J., Barton, F. B., Eckert, S. V., McMahon, R. P., & Bonds, D. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322001 · Cited by 2,340
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Kato, G. J., Gladwin, M. T., & Steinberg, M. H. (2007) · Blood Reviews · doi:10.1016/j.blre.2006.07.001 · Cited by 876
Characterization of Heme as Activator of Toll-like Receptor 4
Figueiredo, R. T., Fernandez, P. L., Mourao-Sa, D. S., Porto, B. N., Dutra, F. F., Alves, L. S., Oliveira, M. F., Oliveira, P. L., Graça-Souza, A. V., & Bozza, M. T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610737200 · Cited by 576 · cited 1×
“Haem also incites oxidative stress and haem oxygenase (HO)-1 expression in macrophages (Figueiredo et al, 2007).”
BackgroundAcute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course
Vichinsky, E. P., Styles, L. A., Colangelo, L. H., Wright, E. C., Castro, O., Nickerson, B., & Disease, T. C. S. O. S. C. (1997) · Blood · doi:10.1182/blood.v89.5.1787 · Cited by 573 · cited 11×
“Activated polymorphonuclear neutrophils (PMNs) can bind to red blood cells via interactions between CD11b (ITGAM)/CD18 (ITGB2) with various receptors on red blood cells (Hofstra et al, 1996).”
BackgroundInfluentialTransgenic Knockout Mice with Exclusively Human Sickle Hemoglobin and Sickle Cell Disease
Pászty, C., Brion, C. M., Manci, E., Witkowska, H. E., Stevens, M. E., Mohandas, N., & Rubin, E. M. (1997) · Science · doi:10.1126/science.278.5339.876 · Cited by 467
Flick, M. J., Du, X., Witte, D. P., Jiroušková, M., Soloviev, D. A., Busuttil, S. J., Plow, E. F., & Degen, J. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20741 · Cited by 450
Polanowska-Grabowska, R., Wallace, K., Field, J. J., Chen, L., Marshall, M. A., Figler, R., Gear, A. R. L., & Linden, J. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.211615 · Cited by 189
Porto, B. N., Alves, L. S., Fernández, P. L., Dutra, T. P., Figueiredo, R. T., Graça-Souza, A. V., & Bozza, M. T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703570200 · Cited by 161
Pulmonary Artery Thrombosis during Acute Chest Syndrome in Sickle Cell Disease
Dessap, A. M., Deux, J.-F., Abidi, N., Lavenu-Bombled, C., Melica, G., Renaud, B., Godeau, B., Adnot, S., Brochard, L., Brun-Buisson, C., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0783oc · Cited by 144
Research works printed but not linked: 139
- 10.1182/blood-2008-06-165845 · DOI · Paper page
- 10.1001/archneur.64.11.1567 · DOI
- Adedeji M.O., 2001, Pulmonary thrombotic arteriopathy in patients with sickle cell disease, Archives of Pathology and Laboratory Medicine, 125, 1436, 10.5858/2001-125-1436-PTAIPW · DOI
- 10.1111/j.1538-7836.2011.04488.x · DOI · Paper page
- 10.1038/295612a0 · DOI
- 10.3324/haematol.2009.013672 · DOI · Paper page
- 10.1182/asheducation-2007.1.91 · DOI · Paper page
- 10.3324/haematol.11763 · DOI · Paper page
- 10.1371/journal.pone.0029786 · DOI
- 10.3109/10409238809082548 · DOI · Paper page
- 10.1038/nm.2461 · DOI · Paper page
- 10.3324/haematol.12632 · DOI
- 10.3324/haematol.2009.008938 · DOI · Paper page
- 10.1182/blood.V96.7.2451 · DOI · Paper page
- 10.1182/blood-2002-10-3313 · DOI · Paper page
- 10.1016/j.tracli.2008.04.001 · DOI
- 10.1073/pnas.1006774107 · DOI · Paper page
- Cabannes R., 1984, Clinical and biological double‐blind‐study of ticlopidine in preventive treatment of sickle‐cell disease crises, Agents and Actions Supplements, 15, 199
- 10.1073/pnas.97.10.5255 · DOI · Paper page
- Camus S.M., 2012, Erythrocyte Microparticles can Induce Kidney Vaso‐Occlusions in a Murine Model of Sickle Cell Disease, 10.1182/blood-2012-02-413138 · DOI
- 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6 · DOI
- 10.1182/blood-2012-04-424143 · DOI
- 10.1182/blood-2012-04-424143 · DOI
- 10.1055/s-0038-1650055 · DOI
- Chaplin H., 1989, Preliminary trial of minidose heparin prophylaxis for painful sickle cell crises, East African Medical Journal, 66, 574
- 10.1182/blood-2009-03-213967 · DOI
- 10.1182/blood-2010-08-302539 · DOI
- 10.1111/j.1538-7836.2012.04861.x · DOI
- 10.1016/0005-2736(91)90247-6 · DOI
- 10.1182/blood-2012-06-437772 · DOI · Paper page
- 10.1055/s-0031-1273087 · DOI · Paper page
- 10.1182/blood-2002-05-1401 · DOI · Paper page
- Drake T.A., 1989, Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis, American Journal of Pathology, 134, 1087
- 10.1016/S0049-3848(01)00247-X · DOI
- 10.1055/s-0038-1646375 · DOI · Paper page
- Eikelboom J.W., 2010, New Anticoagulants, 121, 1523
- 10.1016/0049-3848(90)90148-6 · DOI · Paper page
- 10.1177/153537020422901104 · DOI
- 10.1182/blood-2002-07-2135 · DOI
- Francis R.B., 1988, Protein S deficiency in sickle cell anemia, Journal of Laboratory and Clinical Medicine, 111, 571
- 10.1097/00001721-199104000-00018 · DOI
- 10.1172/JCI111672 · DOI · Paper page
- 10.1097/00062752-200203000-00003 · DOI · Paper page
- 10.1172/JCI30920 · DOI · Paper page
- 10.1111/j.1365-2141.2012.09218.x · DOI
- 10.1182/blood-2010-08-301366 · DOI
- 10.1182/blood.V85.1.268.bloodjournal851268 · DOI · Paper page
- 10.1160/TH11-10-0689 · DOI
- Ghosh S., 2011, Toll‐like receptor 4 mediates heme induced acute lung injury: Preclinical Study of Resatorvid in Sickle Cell Disease, Blood, 118, 926, 10.1182/blood.V118.21.2113.2113 · doi:10.1182/blood.v118.21.2113.2113
- 10.1155/2012/582018 · DOI
- 10.1002/ajh.2830230403 · DOI
- 10.1016/S0022-3476(83)80258-3 · DOI
- Guo Y., 2008, The Protein C pathway in human and murine sickle cell disease: alterations in Protein C, thrombomodulin (TM), and endothelial Protein C receptor (EPCR) at baseline and during acute vaso‐occlusion, Blood, 112, 202
- Guo Y.H.H., 2010, Low molecular weight heparin reduces sVCAM‐1 and lung congestion in a murine model of sickle cell disease, Blood, 116, 686
- 10.1182/blood-2010-05-285718 · DOI
- 10.1159/000204390 · doi:10.1159/000204390
- 10.1080/10739680490278402 · DOI · Paper page
- 10.2174/1871529X10909040271 · DOI
- 10.1182/blood-2009-02-204990 · DOI
- 10.1038/nm.1939 · DOI · Paper page
- 10.1080/10739680490278600 · DOI · Paper page
- Hillery C.A., 2004, Tissue factor deficiency decreases sickle cell‐induced vascular stasis in a hematopoietic stem cell transplant model of murine sickle cell disease, Blood, 104, 71a, 10.1182/blood.V104.11.236.236 · doi:10.1182/blood.v104.11.236.236
- 10.1182/blood.V87.10.4440.bloodjournal87104440 · DOI
- 10.1111/j.1365-2141.2010.08480.x · DOI
- 10.1111/bcp.12042 · DOI
- 10.1016/j.ajog.2005.11.008 · DOI · Paper page
- Joneckis C.C., 1993, Integrin alpha 4 beta 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia, Blood, 82, 3548, 10.1182/blood.V82.12.3548.3548 · DOI · Paper page
- 10.1136/jcp.33.7.622 · DOI · Paper page
- 10.1182/blood.V91.11.4216 · DOI · Paper page
- 10.1055/s-2007-1006393 · doi:10.1055/s-2007-1006393
- 10.1016/j.trsl.2009.10.004 · DOI
- 10.1016/j.thromres.2007.12.004 · doi:10.1016/j.thromres.2007.12.004
- 10.1002/ajh.23147 · DOI
- 10.1002/jlb.66.3.411 · DOI · Paper page
- 10.1161/01.ATV.0000220374.00602.a2 · DOI
- 10.1111/j.1365-2141.1975.tb00530.x · DOI
- 10.1161/01.ATV.20.10.2322 · DOI · Paper page
- 10.1182/blood-2012-07-444455 · DOI
- 10.1172/JCI60229 · DOI · Paper page
- 10.1161/ATVBAHA.107.141911 · DOI · Paper page
- 10.1097/01.mbc.0000164431.98169.8f · doi:10.1097/01.mbc.0000164431.98169.8f
- 10.1001/jama.294.1.81 · DOI · Paper page
- 10.1182/blood.V32.5.811.811 · DOI · Paper page
- 10.1007/s00464-002-4529-2 · doi:10.1007/s00464-002-4529-2
- 10.1002/ajh.22206 · DOI
- 10.1111/j.1538-7836.2012.04697.x · DOI
- Oppenheimer E.H., 1971, Pulmonary changes in sickle cell disease, The American Review of Respiratory Disease, 103, 858
- 10.1159/000207105 · doi:10.1159/000207105
- 10.1161/CIRCRESAHA.110.233056 · DOI · Paper page
- 10.1002/ajh.20196 · DOI
- 10.1160/TH04-05-0309 · DOI
- 10.1182/blood-2009-12-259267 · DOI · Paper page
- Peters M., 1994, Enhanced thrombin generation in children with sickle cell disease, Thrombosis and Haemostasis, 71, 169
- 10.1038/nm1198 · DOI · Paper page
- 10.1002/ana.10192 · DOI · Paper page
- 10.1111/j.1365-2141.2010.08087.x · DOI
- 10.1160/Th06-12-0718 · DOI
- 10.1177/1076029611420992 · DOI
- 10.1161/01.ATV.0000151624.45775.13 · DOI · Paper page
- Redecha P., 2008, Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome, The Journal of Clinical Investigation, 118, 3453
- 10.1016/S0140-6736(10)61029-X · DOI · Paper page
- 10.1002/ajh.20982 · DOI
- 10.1016/j.thromres.2007.03.011 · DOI · Paper page
- 10.1056/NEJM196307252690403 · DOI
- 10.1182/blood-2006-01-023713 · DOI
- 10.1002/ajh.1175 · DOI
- 10.1055/s-0038-1661088 · DOI
- 10.1182/blood.V96.3.1119.015k53_1119_1124 · DOI
- 10.1182/blood.V98.12.3228 · DOI · Paper page
- 10.1111/j.1538-7836.2008.03177.x · DOI
- Setty B.N., 2012, Tissue Factor‐Positive Monocytes in Children With Sickle Cell Disease: Correlation With Biomarkers of Haemolysis
- 10.1182/blood-2003-03-0693 · DOI · Paper page
- 10.2174/156652408786241366 · doi:10.2174/156652408786241366
- 10.1111/j.1540-8175.2010.01201.x · doi:10.1111/j.1540-8175.2010.01201.x
- 10.1172/JCI1932 · DOI · Paper page
- 10.1182/blood-2003-10-3719 · DOI · Paper page
- 10.1002/ajh.21582 · DOI
- Sparkenbaugh E.M., 2012, Heme Induces Systemic Activation of Coagulation in vivo in a Tissue Factor‐Dependent Manner, Blood (ASH Annual Meeting Abstracts), 120, 820
- 10.1016/j.amjmed.2006.08.015 · DOI · Paper page
- 10.1001/jama.289.13.1645 · DOI · Paper page
- 10.1080/15513810109168816 · DOI
- 10.1177/088307389701200103 · DOI
- 10.1067/mlc.2001.115450 · DOI · Paper page
- Tomer A., 2001, Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n‐3 fatty acids, Thrombosis and Haemostasis, 85, 966, 10.1055/s-0037-1615948 · DOI
- 10.1182/blood.V84.9.3189.3189 · DOI
- 10.1073/pnas.052522799 · DOI · Paper page
- 10.1111/j.1538-7836.2012.04758.x · DOI · Paper page
- 10.3181/00379727-216-44197 · DOI · Paper page
- 10.1182/blood.V98.6.1802 · DOI · Paper page
- 10.1182/blood-2009-02-205492 · DOI
- 10.1074/jbc.M703586200 · DOI
- 10.1016/S0022-2143(99)90149-X · DOI
- Westwick J., 1983, Platelet activation during steady state sickle cell disease, Journal of Medicine, 14, 17
- 10.1172/JCI113151 · DOI
- 10.1111/j.1365-2141.1995.tb05607.x · DOI
- 10.1182/blood-2006-02-004812 · DOI · Paper page
- 10.1046/j.1365-2141.1998.00627.x · DOI
- 10.1159/000206360 · DOI
- 10.1160/TH08-10-0677 · DOI
Cited by
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies
Manwani, D., & Frenette, P. S. (2013) · Blood · doi:10.1182/blood-2013-05-498311 · Cited by 428
Zhang, D., Xu, C., Manwani, D., & Frenette, P. S. (2016) · Blood · doi:10.1182/blood-2015-09-618538 · Cited by 413
Oteng-Ntim, E., Meeks, D., Seed, P. T., Webster, L., Howard, J., Doyle, P., & Chappell, L. C. (2015) · Blood · doi:10.1182/blood-2014-11-607317 · Cited by 271
Neutrophil Extracellular Traps Drive Endothelial-to-Mesenchymal Transition
Pieterse, E., Rother, N., Garsen, M., Hofstra, J. M., Satchell, S. C., Hoffmann, M., Loeven, M. A., Knaapen, H. K., van der Heijden, O. W. H., Berden, J. H. M., et al. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.309002 · Cited by 253
Metadata
- Authors
- Sparkenbaugh, E., & Pawlinski, R.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2013-04-18
- Volume
- 162
- Issue
- 1
- Pages
- 3-14
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W1980573671
- Cited by
- 171
- References
- 13
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.